188 related articles for article (PubMed ID: 31703396)
1. Untargeted Urinary
Silva CL; Olival A; Perestrelo R; Silva P; Tomás H; Câmara JS
Metabolites; 2019 Nov; 9(11):. PubMed ID: 31703396
[TBL] [Abstract][Full Text] [Related]
2. An integrative approach based on GC-qMS and NMR metabolomics data as a comprehensive strategy to search potential breast cancer biomarkers.
Silva CL; Perestrelo R; Capelinha F; Tomás H; Câmara JS
Metabolomics; 2021 Aug; 17(8):72. PubMed ID: 34389918
[TBL] [Abstract][Full Text] [Related]
3. Implementing a central composite design for the optimization of solid phase microextraction to establish the urinary volatomic expression: a first approach for breast cancer.
Silva CL; Perestrelo R; Silva P; Tomás H; Câmara JS
Metabolomics; 2019 Apr; 15(4):64. PubMed ID: 30997581
[TBL] [Abstract][Full Text] [Related]
4. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.
Wang Z; Lin Y; Liang J; Huang Y; Ma C; Liu X; Yang J
Oncotarget; 2017 Dec; 8(62):105819-105831. PubMed ID: 29285295
[TBL] [Abstract][Full Text] [Related]
5. Volatomic pattern of breast cancer and cancer-free tissues as a powerful strategy to identify potential biomarkers.
Silva C; Perestrelo R; Silva P; Capelinha F; Tomás H; Câmara JS
Analyst; 2019 Jul; 144(14):4153-4161. PubMed ID: 31144689
[TBL] [Abstract][Full Text] [Related]
6. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
[TBL] [Abstract][Full Text] [Related]
7. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
8. Low- and high-grade bladder cancer determination via human serum-based metabolomics approach.
Bansal N; Gupta A; Mitash N; Shakya PS; Mandhani A; Mahdi AA; Sankhwar SN; Mandal SK
J Proteome Res; 2013 Dec; 12(12):5839-50. PubMed ID: 24219689
[TBL] [Abstract][Full Text] [Related]
9. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
10. Urinary metabolomic signature of esophageal cancer and Barrett's esophagus.
Davis VW; Schiller DE; Eurich D; Sawyer MB
World J Surg Oncol; 2012 Dec; 10():271. PubMed ID: 23241138
[TBL] [Abstract][Full Text] [Related]
11. Urinary metabolomic biomarker candidates for skeletal muscle wasting in patients with rheumatoid arthritis.
Oliveira MS; Santo RCE; Silva JMS; Alabarse PVG; Brenol CV; Young SP; Xavier RM
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1657-1669. PubMed ID: 37243418
[TBL] [Abstract][Full Text] [Related]
12. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
[No Abstract] [Full Text] [Related]
13.
Lussu M; Camboni T; Piras C; Serra C; Del Carratore F; Griffin J; Atzori L; Manzin A
BMC Microbiol; 2017 Sep; 17(1):201. PubMed ID: 28934947
[TBL] [Abstract][Full Text] [Related]
14. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
[TBL] [Abstract][Full Text] [Related]
15. Two effective models based on comprehensive lipidomics and metabolomics can distinguish BC versus HCs, and TNBC versus non-TNBC.
Jin Y; Fan S; Jiang W; Zhang J; Yang L; Xiao J; An H; Ren L
Proteomics Clin Appl; 2023 May; 17(3):e2200042. PubMed ID: 36443927
[TBL] [Abstract][Full Text] [Related]
16. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.
Cox IJ; Aliev AE; Crossey MM; Dawood M; Al-Mahtab M; Akbar SM; Rahman S; Riva A; Williams R; Taylor-Robinson SD
World J Gastroenterol; 2016 Apr; 22(16):4191-200. PubMed ID: 27122669
[TBL] [Abstract][Full Text] [Related]
17. Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer.
Loras A; Suárez-Cabrera C; Martínez-Bisbal MC; Quintás G; Paramio JM; Martínez-Máñez R; Gil S; Ruiz-Cerdá JL
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31100982
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
[TBL] [Abstract][Full Text] [Related]
19. Metabolic fingerprinting in breast cancer stages through
Suman S; Sharma RK; Kumar V; Sinha N; Shukla Y
J Pharm Biomed Anal; 2018 Oct; 160():38-45. PubMed ID: 30059813
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
